Business Context and Reporting Period
This Form 8-K filing by Oaktree Acquisition Corp. III Life Sciences (the "Company") reports corporate governance changes effective January 6, 2025. The Company is a Cayman Islands entity with securities trading on The Nasdaq Stock Market LLC under the symbols OACCU, OACC, and OACCW. The filing follows the Company's Initial Public Offering consummated in October 2024.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Resignation: John Frank resigned from the Board of Directors on January 6, 2025. The resignation was not the result of any disagreement regarding operations, policies, or practices.
- Appointments:
- Aman Kumar (existing director) was appointed as the new Chairman of the Board.
- Zaid Pardesi (Chief Executive Officer) was appointed as a Class III director, with a term expiring at the Company's third annual meeting of shareholders.
Outlook, Risks, and Related Party Disclosures
Management confirmed there are no undisclosed arrangements or understandings regarding Mr. Pardesi's appointment. The filing reiterates that Mr. Pardesi and Mr. Kumar have a material interest in the Sponsor, Oaktree Acquisition Holdings III LS, LLC, as previously disclosed in the Final Prospectus. No new transactions or proposed transactions involving Mr. Pardesi were identified that were not previously disclosed under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the updated Board composition and the specific term expiration date for the new Class III director.
- Review the Final Prospectus (filed October 24, 2024) for details on the material interests of Mr. Pardesi and Mr. Kumar in the Sponsor.
- Confirm that no undisclosed related party transactions exist beyond those previously reported.
- Monitor future filings for financial data, as this 8-K contains no operational or financial metrics.